(Q54050054)

24 May 2018

title

Improvement by the insulin-sensitizing agent, troglitazone, of abnormal fibrinolysis in type 2 diabetes mellitus. (English)

1 reference

24 May 2018

0 references

1 reference

Kato K

1

1 reference

24 May 2018

Yamada D

2

1 reference

24 May 2018

Midorikawa S

3

1 reference

24 May 2018

Sato W

4

1 reference

24 May 2018

Watanabe T

5

1 reference

24 May 2018

publication date

1 May 2000

1 reference

24 May 2018

published in

Metabolism

1 reference

24 May 2018

volume

49

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

662-665

1 reference

24 May 2018

Studies of the Effects of an Elevated Glucose Concentration on the Ultrastructure and Composite Metabolism of the Intact Rabbit Aortic Intima-Media Preparation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

The effect of elevated glucose levels on myo-inositol metabolism in cultured bovine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Relationship of oxidative stress and fibrinolysis in diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2980045-1

10.1016/S0026-0495(00)80045-1

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10831180

1 reference

24 May 2018